홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

벤드로플루메티아자이드

Bendroflumethiazide

HCID 2315
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
73-48-3
표준 SMILES
NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O
InChIKey
HDWIHXWEUNVBIY-UHFFFAOYSA-N
분자식
C15H14F3N3O4S2
평균 분자량
421.4 g/mol
단동위원소 질량
421.03778277

개요

Bendroflumethiazide is a sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group. It has a role as a diuretic and an antihypertensive agent. It is a sulfonamide and a benzothiadiazine.

이름 및 식별자

우선 이름
Bendroflumethiazide
IUPAC
3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
현지명
벤드로플루메티아자이드
영어명
BENDROFLUMETHIAZIDE
분자식
C15H14F3N3O4S2
분자량
421.41

이름 및 동의어

BENDROFLUMETHIAZIDEBendrofluazide73-48-3NaturetinAprinoxBenzhydroflumethiazideBenzylrodiuranCentylPlurylBentrideBristuricBristuron
이름 더 보기
벤드로플루메티아자이드벤드로플루메티아자이드및그유도체ft8bhftft81relanurleablh368nikionorsile
FlumesilNiagarilPlusurilPoliuronSinesalinSodiureticThiazidicoIntolex

데이터베이스 식별자

CAS
73-48-3
PubChem CID
2315
DTXSID
DTXSID5022647
ChEMBL
CHEMBL1684
ChEBI
CHEBI:3013
UNII
5Q52X6ICJI
EC Number
200-800-1

물성

구조 계산 물성보충 중

XLogP
1.2
극성 표면적
135 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
10
회전 가능 결합 수
3
무거운 원자 수
27
형식 전하
0
복잡도
740

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Cardiovascular system -> Diuretics
LogP · 3건

log Kow = 1.19

1.7

1.78

OdorODORLESS OR HAS SLIGHT, CHARACTERISTIC FLORAL ODOR
Color/Form · 2건

Crystals from dioxane.

WHITE TO CREAM-COLORED, FINELY DIVIDED, CRYSTALLINE POWDER

Solubility · 5건

FREELY SOL IN ALC & ACETONE

Insoluble in chloroform, benzene, ether.

In water, 108.3 mg/l at 25 °C.

2.14e-01 g/L

>63.2 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 4건

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Thiazide Diuretics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

DecompositionWhen heated to decomposition it emits toxic fumes of /hydrogen fluoride/, sulfoxides, and nitroxides.
Melting Point · 3건

222-223 °C

224.5 to 225.5 °C (also reported as 221 to 223 °C)

221 - 223 °C

Physical DescriptionSolid
Dissociation Constants8.5
Collision Cross Section · 2건

188.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

189.03 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
205 · 205-207°C
끓는 점
602.1 · 602.1±65.0 °C(Predicted)
밀도
1.4711 · 1.4711 (estimate)
저장 조건
Refrigerator
용해도
물에는 거의 녹지 않으며, 아세톤에는 잘 녹고, 에탄올에는 녹습니다(96%).
산도 계수 (pKa)
8.53 · pKa 8.53±0.05(H2O t=25 I=0.2) (Uncertain)
물리적 상태
Solid
색상
3 · MeOH/CHCl3에서 결정화된 결정
수용성
40 mg/L · 40mg/L(상온)
EPA
2 H-1,2,4-Benzothiadiazine-7-sulfonamide, · 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide (73-48-3)

화학적 성질

White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 3건

This chemical does not meet GHS hazard criteria for 91.5% (54 of 59) of all reports.

Not Classified

Aggregated GHS information provided per 59 reports by companies from 6 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationBendroflumethiazide: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide: Environment tier I assessment
FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesNot Classified

안전 및 보호

Storage ConditionsBendroflumethiazide tablets should be stored in tight containers at room temperature and protected from excessive heat.
Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

독성 정보

Interactions · 5건

MANY DIABETIC PATIENTS REGULATED BY CHLORPROPAMIDE OR OTHER SULFONYLUREAS EXHIBIT IMPAIRED DIABETIC CONTROL WHEN ANY THIAZIDE DIURETIC IS ADDED TO DRUG REGIMEN. /THIAZIDE DIURETICS/

...CARDIAC GLYCOSIDE & DIURETIC; DIURETIC-INDUCED HYPOKALEMIA POTENTIATES CARDIOTOXICITY OF GLYCOSIDE. /DIURETICS/

THIAZIDES ENHANCE ANTIHYPERTENSIVE ACTION OF GUANETHIDINE, ALLOWING DOSE OF GUANETHIDINE TO BE REDUCED & DECR INCIDENCE OF ADVERSE REACTIONS... /THIAZIDE DIURETICS/

...DIURETICS MAY INCR CONCN OF CLOTTING FACTORS BY LOSS OF PLASMA VOL & INCR CLOTTING FACTOR SYNTH BY REDUCING HEPATIC CONGESTION, THEREBY ANTAGONIZING EFFECT OF ORAL ANTICOAGULANTS. /DIURETICS, THIAZIDE/

For more Interactions (Complete) data for BENDROFLUMETHIAZIDE (21 total), please visit the HSDB record page.

Human Toxicity Excerpts · 3건

BORDERLINE RENAL &/OR HEPATIC INSUFFICIENCY MAY BE UNPREDICTABLY AGGRAVATED BY THIAZIDES. ... IN CIRRHOSIS OF LIVER, DETERIORATION OF MENTAL FUNCTION, INCL ONSET OF COMA, HAS BEEN ATTRIBUTED TO THIAZIDE THERAPY. ... THIAZIDES MAY INDUCE HYPERGLYCEMIA & AGGRAVATE PREEXISTING DIABETES MELLITUS. /THIAZIDE DIURETICS/

In addition to diuresis and resultant dehydration, overdosage of thiazides may produce lethargy, nausea, weakness, and electrolyte imbalance; lethargy may progress to coma within a few hours with minimal depression of respiratory and cardiovascular function and without evidence of dehydration or serum electryolye change. The mechanism of thiazide-induced CNS depression is unknown. GI irritation and hypermotility may occur, and temporary elevation of the BUN has been reported. Serum electrolyte changes (e.g., hypokalemia, hypochloremia, hyponatremia) may occur, especially in patients with impaired renal function. /Thiazides/

May suppress lactation, but compatible /SRP: with breast feeding/. /Thiazide diuretics, from table/

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Bendroflumethiazide

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Antidote and Emergency TreatmentThiazide diuretic overdose should be treated by immediate evacuation of the stomach followed by supportive symptomatic treatment and monitoring of serum electrolyte concentrations and renal function. /Thiazide diuretic/
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Non-Human Toxicity Values · 4건

LD50 MOUSE ORAL EXCEEDS 8000 MG/KG

LD50 MOUSE INTRAPERITONEAL 8000 MG/KG

LD50 Mouse ip 4800 mg/kg

LD50 Mouse iv 395 mg/kg

EPA Human Health Benchmarks for Pharmaceuticals · 6건

Bendroflumethiazide

0.1

0.5

Bendroflumethiazide is given in combination with nadolol in a tablet. Each tablet contains 40 mg or 80 mg nadolol combined with 5 mg bendroflumethiazide. Bendroflumethiazide is usually given at a dose of 5 mg daily.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 5 mg/day, Lowest Therapeutic Dose (LTD): 0.1 mg/kg-day, and Screening Dose: 0.00002 mg/kg-day.

15-Apr-16

규제 정보

FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

안전 데이터

wgk
2
rtecs
DK8225000
독성
LD50 oral in mouse: > 10gm/kg
HS 번호
2935904000
유해 물질 데이터
73-48-3(Hazardous Substances Data)

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

Protein Binding96%
Pharmacodynamics · 1건

Bendroflumethiazide, a thiazide diuretic, removes excess water from the body by increasing how often you urinate (pass water) and also widens the blood vessels which helps to reduce blood pressure. It inhibits Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Mechanism of Action · 6건

As a diuretic, bendroflumethiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like bendroflumethiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of bendroflumethiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

...BENZOTHIADIAZIDES HAVE DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE...INDEPENDENT OF ANY EFFECT ON CARBONIC ANHYDRASE. /THIAZIDE DIURETICS/

NATURE OF CHEM INTERACTION BETWEEN THIAZIDES & SPECIFIC RENAL RECEPTORS RESPONSIBLE FOR CHLORURETIC EFFECT IS NOT KNOWN; NO CRITICAL ENZYMATIC REACTIONS HAVE BEEN IDENTIFIED. /THIAZIDE DIURETICS/

...MAY DECR EXCRETION OF URIC ACID IN MAN, THUS INCR ITS CONCN IN PLASMA. HYPERURICEMIC EFFECT RESULTS PRIMARILY FROM INHIBITION OF TUBULAR SECRETION OF URATE. ... UNLIKE MOST OTHER NATRIURETIC AGENTS...DECR RENAL EXCRETION OF CALCIUM RELATIVE TO THAT OF SODIUM... /ENHANCE/ EXCRETION OF MAGNESIUM... /THIAZIDE DIURETICS/

THIAZIDES INHIBIT REABSORPTION OF SODIUM &...CHLORIDE IN DISTAL SEGMENT. ... AS CLASS...HAVE IMPORTANT ACTION ON EXCRETION OF POTASSIUM THAT RESULTS FROM INCR SECRETION OF CATION BY DISTAL TUBULE. ... GLOMERULAR FILTRATION RATE MAY BE REDUCED BY THIAZIDES, PARTICULARLY WITH IV ADMIN FOR EXPTL PURPOSES. /THIAZIDE DIURETICS/

For more Mechanism of Action (Complete) data for BENDROFLUMETHIAZIDE (11 total), please visit the HSDB record page.

Biological Half-Life · 2건

8.5 hours

Halflife is 3-3.9 hrs. /From table/

FDA Pharmacological Classification · 6건

5Q52X6ICJI

BENDROFLUMETHIAZIDE

Physiologic Effects [PE] - Increased Diuresis

Established Pharmacologic Class [EPC] - Thiazide Diuretic

Chemical Structure [CS] - Thiazides

Bendroflumethiazide is a Thiazide Diuretic. The physiologic effect of bendroflumethiazide is by means of Increased Diuresis.

MeSH Pharmacological Classification · 3건

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Agents that promote the excretion of urine through their effects on kidney function.

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Absorption, Distribution and Excretion · 6건

Absorbed relatively rapidly after oral administration

MOST CMPD ARE RAPIDLY EXCRETED WITHIN 3-6 HR. BENDROFLUMETHIAZIDE...LONGER DURATION OF ACTION THAT IS CORRELATED WITH...SLOWER EXCRETION.

THIAZIDES ARE ABSORBED FROM GI TRACT & OWE THEIR USEFULNESS LARGELY TO THEIR EFFECTIVENESS BY ORAL ROUTE. ABSORPTION IS RELATIVELY RAPID. MOST AGENTS SHOW DEMONSTRABLE DIURETIC EFFECT WITHIN HR AFTER ORAL ADMIN. /BENZOTHIADIAZIDES/

IN GENERAL, THIAZIDES WITH RELATIVELY LONG DURATIONS OF ACTION SHOW PROPORTIONATELY HIGH DEGREE OF BINDING TO PLASMA PROTEINS & ARE REABSORBED... BY RENAL TUBULES. ... DRUG PASSES READILY THROUGH PLACENTAL BARRIER TO FETUS. ALL THIAZIDES PROBABLY UNDERGO ACTIVE SECRETION IN PROXIMAL TUBULE. /THIAZIDE DIURETICS/

BENDROFLUMETHIAZIDE WAS ADMIN ORALLY TO 9 HEALTHY VOLUNTEERS. PEAK PLASMA LEVELS REACHED @ 1 + OR - 0.4 HR. CONCN DECLINED WITH MEAN T/2 OF 3 HR. APPARENT VOL OF DISTRIBUTION AVG 1.48 L/KG. MAJOR PART ELIMINATED VIA NONRENAL MECHANISMS. URINARY RECOVERY AVG 30%.

Bendroflumethiazide appears to be well absorbed from the GI tract. The drug is excreted unchanged in urine, and excretion is essentially complete within 24 hours.

Cellular LocationsCytoplasm
Metabolite PathwaysBendroflumethiazide Action Pathway

용도 및 제조

Uses · 2건

MEDICATION

THERAP CAT: Diuretic, antihypertensive.

Methods of ManufacturingPrepn: C.T. Holdrege et al., J Am Chem Soc 81, 4807 (1959); F. Lund, W.O. Godtfredsen, Brit pat 863,474; eidem, U.S. pat 3,392,168 (1961, 1968 both to Lovens Kemiske Fabrik)..
Formulations/PreparationsDOSAGE FORMS- TABLETS NF: 2.5, 5, & 10 MG.
Use ClassificationPharmaceuticals
응용 분야 · 2건

개요Bendroflumethiazide (Item No. 21311) is an analytical reference standard categorized as a diuretic. Diuretics, including bendroflumethiazide, have been abused as performance-enhancing drugs and masking agents in sports doping. This product is intended for research and forensic applications.

용도Bendroflumethiazide may be used for the same indications as the aforementioned drugs; however, it is primarily used as an adjuvant agent for relieving edema associated with cardiac insufficiency, liver cirrhosis, and edema caused by taking corticosteroids.

상·하류 제품 정보

상류 원료

3-니트로벤조트리플로라이드벤조트리플루오라이드Aminosulfonate벤조트리클로라이드페닐 아세트알데히드철분메타-(트라이플루오로메틸)아닐린암모니아(가스)클로로술폰산

추가 설명

정의ChEBI: A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트